These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25459914)

  • 1. NNT pseudoexon activation as a novel mechanism for disease in two siblings with familial glucocorticoid deficiency.
    Novoselova TV; Rath SR; Carpenter K; Pachter N; Dickinson JE; Price G; Chan LF; Choong CS; Metherell LA
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E350-4. PubMed ID: 25459914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD).
    Jazayeri O; Liu X; van Diemen CC; Bakker-van Waarde WM; Sikkema-Raddatz B; Sinke RJ; Zhang J; van Ravenswaaij-Arts CM
    Eur J Med Genet; 2015 Dec; 58(12):642-9. PubMed ID: 26548497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency.
    Yamaguchi R; Kato F; Hasegawa T; Katsumata N; Fukami M; Matsui T; Nagasaki K; Ogata T
    Endocr J; 2013; 60(7):855-9. PubMed ID: 23474776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.
    Roucher-Boulez F; Mallet-Motak D; Samara-Boustani D; Jilani H; Ladjouze A; Souchon PF; Simon D; Nivot S; Heinrichs C; Ronze M; Bertagna X; Groisne L; Leheup B; Naud-Saudreau C; Blondin G; Lefevre C; Lemarchand L; Morel Y
    Eur J Endocrinol; 2016 Jul; 175(1):73-84. PubMed ID: 27129361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.
    Meimaridou E; Kowalczyk J; Guasti L; Hughes CR; Wagner F; Frommolt P; Nürnberg P; Mann NP; Banerjee R; Saka HN; Chapple JP; King PJ; Clark AJ; Metherell LA
    Nat Genet; 2012 May; 44(7):740-2. PubMed ID: 22634753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Three Family Members with a Novel
    Krasovec T; Sikonja J; Zerjav Tansek M; Debeljak M; Ilovar S; Trebusak Podkrajsek K; Bertok S; Tesovnik T; Kovac J; Suput Omladic J; Hartmann MF; Wudy SA; Avbelj Stefanija M; Battelino T; Kotnik P; Groselj U
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined mineralocorticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress.
    Weinberg-Shukron A; Abu-Libdeh A; Zhadeh F; Carmel L; Kogot-Levin A; Kamal L; Kanaan M; Zeligson S; Renbaum P; Levy-Lahad E; Zangen D
    J Med Genet; 2015 Sep; 52(9):636-41. PubMed ID: 26070314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD).
    Prasad R; Chan LF; Hughes CR; Kaski JP; Kowalczyk JC; Savage MO; Peters CJ; Nathwani N; Clark AJ; Storr HL; Metherell LA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1556-63. PubMed ID: 24601690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide Nucleotide Transhydrogenase Is Essential for Adrenal Steroidogenesis: Clinical and In Vitro Lessons.
    Bodoni AF; Coeli-Lacchini FB; Gebenlian JL; Sobral LM; Garcia CB; Silva WA; Peronni KC; Ramalho LNZ; Ramalho FS; Moreira AC; de Castro M; Leopoldino AM; Antonini SRR
    J Clin Endocrinol Metab; 2023 May; 108(6):1464-1474. PubMed ID: 36478070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the NNT gene causing familial glucocorticoid deficiency, with a literature review.
    Pons Fernández N; Moriano Gutiérrez A; Taberner Pazos B; Tarragon Cros A; Díez Gandía E; Zuñiga Cabrera Á
    Ann Endocrinol (Paris); 2024 Feb; 85(1):70-81. PubMed ID: 37352919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated glucocorticoid deficiency: Genetic causes and animal models.
    Maharaj A; Maudhoo A; Chan LF; Novoselova T; Prasad R; Metherell LA; Guasti L
    J Steroid Biochem Mol Biol; 2019 May; 189():73-80. PubMed ID: 30817990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency.
    Metherell LA; Naville D; Halaby G; Begeot M; Huebner A; Nürnberg G; Nürnberg P; Green J; Tomlinson JW; Krone NP; Lin L; Racine M; Berney DM; Achermann JC; Arlt W; Clark AJ
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3865-71. PubMed ID: 19773404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.
    Li L; Ma J; Wang J; Dong L; Liu S
    Eur J Med Res; 2022 Sep; 27(1):184. PubMed ID: 36155627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing identifies novel compound heterozygous mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa.
    Méndez-Vidal C; González-Del Pozo M; Vela-Boza A; Santoyo-López J; López-Domingo FJ; Vázquez-Marouschek C; Dopazo J; Borrego S; Antiñolo G
    Mol Vis; 2013; 19():2187-95. PubMed ID: 24227914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
    Petersen USS; Doktor TK; Andresen BS
    Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: a Novel Cause of Severe Growth Hormone Insensitivity.
    Cottrell E; Maharaj A; Williams J; Chatterjee S; Cirillo G; Miraglia Del Giudice E; Festa A; Palumbo S; Capalbo D; Salerno M; Pignata C; Savage MO; Schilbach K; Bidlingmaier M; Hwa V; Metherell LA; Grandone A; Storr HL
    J Clin Endocrinol Metab; 2021 Jul; ():. PubMed ID: 34453441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency.
    Hershkovitz E; Arafat M; Loewenthal N; Haim A; Parvari R
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1187-90. PubMed ID: 25879317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAR mutations causing non‑classical lipoid adrenal hyperplasia manifested as familial glucocorticoid deficiency.
    Luo Y; Bai R; Wang Z; Zhu X; Xing J; Li X
    Mol Med Rep; 2020 Aug; 22(2):681-686. PubMed ID: 32627004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations.
    Amiri-Yekta A; Coutton C; Kherraf ZE; Karaouzène T; Le Tanno P; Sanati MH; Sabbaghian M; Almadani N; Sadighi Gilani MA; Hosseini SH; Bahrami S; Daneshipour A; Bini M; Arnoult C; Colombo R; Gourabi H; Ray PF
    Hum Reprod; 2016 Dec; 31(12):2872-2880. PubMed ID: 27798045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model.
    Scott R; Van Vliet G; Deladoëy J
    Eur J Endocrinol; 2017 Mar; 176(3):C1-C2. PubMed ID: 28049652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.